The role of kidney biopsy in the management of lupus nephritis

Current Opinion in Nephrology and Hypertension

Volumn 14, Issue 1, 2005, Pages 1-8

  Mittal, Bharati ^a   Rennke, Helmut ^a   Singh, Ajay K ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Glomerulonephritis; Lupus nephritis; Renal biopsy; Systemic lupus erythematosus

Indexed keywords

CYCLOPHOSPHAMIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

CHRONICITY; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; DISEASE SEVERITY; GLOMERULONEPHRITIS; HIGH RISK PATIENT; HUMAN; KIDNEY BIOPSY; LONG TERM CARE; LUPUS ERYTHEMATOSUS NEPHRITIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SCORING SYSTEM; SEROLOGY; SHORT COURSE THERAPY; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT PLANNING; URINALYSIS; WORLD HEALTH ORGANIZATION;

BIOPSY, NEEDLE; EVALUATION STUDIES; HUMANS; KIDNEY; LUPUS NEPHRITIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 12144274803     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-200501000-00002     Document Type: Review

References (61)

1. Neumann K, Wallace DJ, Azen C, et al. Lupus in the 1980s: III. Influence of clinical variables, biopsy, and treatment on the outcome in 150 patients with lupus nephritis seen at a single center. Semin Arthritis Rheum 1995; 25:47-55.
2. Salach RH, Cash JM. Managing lupus nephritis: algorithms for conservative use of renal biopsy. Cleveland Clin J Med 1996; 63:106-115.
3. Churg J, Bernstein J, Glassock RJ. Renal disease: classification and atlas of glomerular disease, second edition. New York, Tokyo: Igaku-Shoin; 1995. pp. 151-156.
4. Weening JJ, D'Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 2004; 65:521-530.
5. Balow JE, Boumpas DT, Austin HA III. New prospects for treatment of lupus nephritis. Semin Nephrol 2000; 20:32-39.
6. Bansal VK, Beto JA. Treatment of lupus nephritis: a meta-analysis of clinical trials. Am J Kidney Dis 1997; 29:193-199.
7. Donadio JV Jr, Glassock RJ. Immunosuppressive drug therapy in lupus nephritis. Am J Kidney Dis 1003; 21:239-250.
8. Bono L, Cameron JS, Hicks JA. The very long-term prognosis and complications of lupus nephritis and its treatment. Q J Med 1999; 92:211-218.
9. Contreras G, Pardo V, Leclercq B, et al. Sequential therapies for proliferative lupus nephritis. N Engl J Med 2004; 350:971-980.
10. Cameron JS. Lupus nephritis: an historical perspective 1968-1998. J Nephrol 1999; 12 (Suppl. 2):S29-S41.
11. Font J, Torras A, Cervera R, et al. Silent renal disease in systemic lupus erythematosus. Clin Nephrol 1987; 27:283-288.
12. Gonzalez-Crespo MR, Lopez-Fernandez JI, Usera G, et al. Outcome of silent lupus nephritis. Semin Arthritis Rheum 1996; 26:468-476.
13. Zabaleta-Lanz M, Vargas-Arenas RE, Tapanes F, et al. Silent nephritis in systemic lupus erythematosus. Lupus 2003; 12:26-30.
14. Leehey DJ, Katz AI, Azaran AH, et al. Silent diffuse lupus nephritis: long-term follow-up. Am J Kidney Dis 1982; 2 (Suppl. 1):188-196.
15. Bennett WM, Bardana EJ, Norman DJ, Houghton DC. Natural history of 'silent' lupus nephritis. Am J Kidney Dis 1982; 1:359-363.
16. Kallen RJ. Nephritis in systemic lupus erythematosus. J Pediatr 1977; 91:509-510.
17. Shearn MA, Hooper J Jr, Biava CG. Membranous lupus nephropathy initially seen as idiopathic membranous nephropathy. Possible diagnostic value of tubular reticular structures. Arch Intern Med 1980; 140:1521-1523.
18. Jennette JC, Iskandar SS, Dalldorf FG. Pathologic differentiation between lupus and nonlupus membranous glomerulopathy. Kidney Int 1983; 24:377-385.
19. Hertig A, Droz D, Lesavre P, et al. SLE and idiopathic nephrotic syndrome: coincidence or not? Am J Kidney Dis 2002; 40:1179-1184.
20. Baranowska-Daca E, Choi YJ, Barrios R, et al. Nonlupus nephritides in patients with systemic lupus erythematosus: a comprehensive clinicopathologic study and review of the literature. Hum Pathol 2001; 32:1125-1135.
21. Queffeulou G, Berenbaum F, Michel C, et al. AA amyloidosis in systemic lupus erythematosus: an unusual complication. Nephrol Dial Transplant 1998; 13:1846-1848.
22. Orellana C, Collado A, Hernandez MV, et al. When does amyloidosis complicate systemic lupus erythematosus? Lupus 1995; 4:415-417.
23. Schwartz MM, Roberts JL, Lewis EJ. Necrotizing glomerulitis of systemic lupus erythematosus. Human Pathol 1983; 14:158-167.
24. Magasic MV, Venkataseshan VS, Vitting KE. Concurrent renal sarcoidosis and lupus nephritis. Nephron 1993; 64:496-497.
25. Ling BN, Bourke E, Campbell WG Jr, Delaney VB. Naproxen-induced nephropathy in systemic lupus erythematosus. Nephron 1990; 54:249-255.
26. McLaughlin J, Gladman DD, Urowitz MB, et al. Kidney biopsy in systemic lupus erythematosus. II. Survival analyses according to biopsy results. Arthritis Rheum 1991; 34:1268-1273.
27. Esdaile JM, Federgreen W, Quintal H, et al. Predictors of one year outcome in lupus nephritis: the importance of renal biopsy. Q J Med 1991; 81:907-918.
28. Esdaile JM, Joseph L, MacKenzie T, et al. The pathogenesis and prognosis of lupus nephritis: information from repeat renal biopsy. Semin Arthritis Rheum 1993; 23:135-148.
29. Ferluga D, Jerse M, Vizjak A, et al. Correlation among WHO classes, histomorphologic patterns of glomerulonephritis and glomerular immune deposits in SLE. Wien Klin Wochenschr 2000; 112:692-701.
30. Nossent HC, Henzen-Logmans SC, Vroom TM, et al. Contribution of renal biopsy data in predicting outcome in lupus nephritis. Analysis of 116 patients. Arthritis Rheum 1990; 33:970-977.
31. Austin HA III, Boumpas DT, Vaughan EM, Balow JE. Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data. Kidney Int 1994; 45:544-550.
32. Austin HA III, Boumpas DT, Vaughan EM, Balow JE. High-risk features of lupus nephritis: importance of race and clinical and histological factors in 166 patients. Nephrol Dial Transplant 1995; 10:1620-1628.
33. Austin HA III, Muenz LR, Joyce KM, et al. Prognostic factors in lupus nephritis. Contribution of renal histologic data. Am J Med 1983; 75:382-391.
34. Grande JP, Balow JE. Renal biopsy in lupus nephritis. Lupus 1998; 7:611-617.
35. Levey AS, Lan SP, Corwin HL, et al. Progression and remission of renal disease in the Lupus Nephritis Collaborative Study. Results of treatment with prednisone and short-term oral cyclophosphamide. Ann Intern Med 1992; 116:114-123.
36. Esdaile JM, MacKenzie T, Barre P, et al. Can experienced clinicians predict the outcome of lupus nephritis? Lupus 1992; 1: 205-214
37. Esdaile JM, Levinton C, Federgreen W, et al. The clinical and renal biopsy predictors of long term outcome in lupus nephritis: a study of 87 patients and review of literature. Q J Med 1989; 269:799-833.
38. Esdaile JM, Abrahamowicz M, MacKenzie T, et al. The time-dependence of long-term prediction in lupus nephritis. Arthritis Rheum 1994; 37:359-368.
39. Arce-Salinas CA, Villa AR, Martinez-Rueda JO, et al. Factors associated with chronic renal failure in 121 patients with diffuse proliferative lupus nephritis: a case-control study. Lupus 1995; 4:197-203.
40. Ward MM, Studenski S. Clinical prognostic factors in lupus nephritis. The importance of hypertension and smoking. Arch Intern Med 1992; 152:2082-2088.
41. Moroni G, Pasquali S, Quaglini S, et al. Clinical and prognostic value of serial renal biopsies in lupus nephritis. Am J Kidney Dis 1999; 34:530-539.
42. Hill GS, Delahousse M, Nochy D, et al. Predictive power of the second renal biopsy in lupus nephritis: significance of macrophages. Kidney Int 2001; 59:304-316.
43. Hill GS, Delahousse M, Nochy D, et al. Outcome of relapse in lupus nephritis: roles of reversal of renal fibrosis and response of inflammation to therapy. Kidney Int 2002; 61:2176-2186.
44. McCluskey RT. Lupus nephritis. In: Sommers SC, editor. Kidney pathology decennial 1966-1975. East Norwalk, CT: Appelton Century Crofts; 1975. p. 435.
45. Churg J, Sobin LH. Renal disease: classification and atlas of glomerular disease. Tokyo: Igaku-Shoin; 1982. pp. 127-131.
46. Mittal BV, Hurwitz S, Rennke HG, Singh AK. New sub-categories of class IV lupus nephritis: are there clinical, histological and outcome differences? Am J Kidney Dis 2004; in press.
47. Najafi CC, Korbet SM, Lewis EJ, et al. Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis. Kidney Int 2001; 59:2156-2163.
48. Wernick RM, Smith DL, Houghton DC, et al. Reliability of histologic scoring for lupus nephritis: a community-based evaluation. Ann Intern Med 1993; 119:805-811.
49. Schwartz MM, Lan SP, Bernstein J, et al. Role of pathology indices in the management of severe lupus glomerulonephritis. Lupus Nephritis Collaborative Study Group. Kidney Int 1992; 42:743-748.
50. Schwartz MM, Lan SP, Bernstein J, et al. Irreproducibility of the activity and chronicity indices limits their utility in the management of lupus nephritis. Lupus Nephritis Collaborative Study Group. Am J Kidney Dis 1993; 21:374-377.
51. Banfi G, Mazzucco G, Barbiano di Belgiojoso G, et al. Morphological parameters in lupus nephritis: their relevance for classification and relationship with clinical and histological findings and outcome. Q J Med 1985; 55:153-168.
52. Balow JE, Austin HA III, Muenz LR, et al. Effect of treatment on the evolution of renal abnormalities in lupus nephritis. N Engl J Med 1984; 311:491-495.
53. Park MH, D'Agati V, Appel GB, Pirani CL. Tubulointerstitial disease in lupus nephritis: relationship to immune deposits, interstitial inflammation, glomerular changes, renal function, and prognosis. Nephron 1986; 44:309-319.
54. Nath KA. Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 1992; 20:1-17.
55. Magil AB, Ballon HS, Chan V, et al. Diffuse proliferative lupus glomerulonephritis. Determination of prognostic significance of clinical, laboratory and pathologic factors. Medicine (Baltimore) 1984; 63:210-220.
56. Hill GS, Delahousse M, Nochy D, et al. A new morphologic index for the evaluation of renal biopsies in lupus nephritis. Kidney Int 2000; 58:1160-1173.
57. Katz SM, Korn S, Umlas SL, DeHoratius RJ. Renal vascular lesions in systemic lupus erythematosus. Ann Clin Lab Sci 1990; 20:147-153.
58. Appel GB, Pirani CL, D'Agati V. Renal vascular complications of systemic lupus erythematosus. J Am Soc Nephrol 1994; 4:1499-1515.
59. Kant KS, Pollak VE, Weiss MA, et al. Glomerular thrombosis in systemic lupus erythematosus: prevalence and significance. Medicine (Baltimore) 1981; 60:71-86.
60. D'Agati V, Kunis C, Williams G, Appel GB. Anti-cardiolipin antibody and renal disease: a report three cases. J Am Soc Nephrol 1990; 1:777-784.
61. Banfi G, Bertani T, Boeri V, et al. Renal vascular lesions as a marker of poor prognosis in patients with lupus nephritis. Gruppo Italiano per lo Studio della Nefrite Lupica (GISNEL). Am J Kidney Dis 1991; 18:240-248.